478
Vanda Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
519
FY23:
433
FY24:
439
FY25:
347
(positive)
Change from FY21 to FY25
millions USD
FY21:
115
FY22:
115
FY23:
215
FY24:
217
FY25:
142
Total assets
Change from FY21 to FY25
millions USD
FY21:
594
FY22:
634
FY23:
648
FY24:
656
FY25:
489
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
74.4
FY22:
91.4
FY23:
87.7
FY24:
100.0
FY25:
145
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.4
FY22:
15.6
FY23:
15.8
FY24:
17.7
FY25:
16.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
505
FY22:
527
FY23:
545
FY24:
539
FY25:
327
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
594
FY22:
634
FY23:
648
FY24:
656
FY25:
489
All amounts in millions USD